User profiles for Simon Thelwall
 | Simon ThelwallUK Health Security Agency Verified email at ukhsa.gov.uk Cited by 8669 |
[HTML][HTML] Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a …
Background The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine
escape and high transmissibility, with early studies indicating lower severity of infection …
escape and high transmissibility, with early studies indicating lower severity of infection …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
…, E Gallagher, R Simmons, S Thelwall… - … England Journal of …, 2021 - Mass Medical Soc
Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
…, E Gallagher, R Simmons, S Thelwall… - The New England …, 2021 - ncbi.nlm.nih.gov
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines
…, R Simmons, E Gallagher, S Thelwall… - … England Journal of …, 2022 - Mass Medical Soc
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
[HTML][HTML] Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant
…, N Iwani Binti Abdul Aziz, S Thelwall… - … England Journal of …, 2022 - Mass Medical Soc
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
Effectiveness of COVID-19 vaccines against the Omicron (B. 1.1. 529) variant of concern
Background A rapid increase in cases due to the SARS-CoV-2 Omicron (B.1.1.529) variant
in highly vaccinated populations has raised concerns about the effectiveness of current …
in highly vaccinated populations has raised concerns about the effectiveness of current …
[HTML][HTML] Context-specific emergence and growth of the SARS-CoV-2 Delta variant
The SARS-CoV-2 Delta (Pango lineage B.1.617.2) variant of concern spread globally, causing
resurgences of COVID-19 worldwide 1 , 2 . The emergence of the Delta variant in the UK …
resurgences of COVID-19 worldwide 1 , 2 . The emergence of the Delta variant in the UK …
[HTML][HTML] Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England
S Thelwall, P Harrington, E Sheridan… - Clinical Microbiology and …, 2015 - Elsevier
We sought to assess the impact of body mass index on the risk of surgical site infection in a
prospective cohort study of 206 National Health Service (NHS) hospitals in England between …
prospective cohort study of 206 National Health Service (NHS) hospitals in England between …
Comparative transmission of SARS-CoV-2 Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) variants and the impact of vaccination: national cohort study, England
…, D Chudasama, S Nash, S Thelwall… - Epidemiology & …, 2023 - cambridge.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529)
rapidly replaced Delta (B.1.617.2) to become dominant in England. Our study …
rapidly replaced Delta (B.1.617.2) to become dominant in England. Our study …
